PAT. NO.

Title
5,344,915 Full-Text
6,090,382 Full-Text
6,258,562 Full-Text
6,509,015 Full-Text
8,420,081 Full-Text
8,498,821 Full-Text
8,722,860 Full-Text
8,753,633 Full-Text
8,795,670 Full-Text
8,802,100 Full-Text
8,802,101 Full-Text
8,802,102 Full-Text
8,821,865 Full-Text
8,877,194 Full-Text
8,883,146 Full-Text
8,889,135 Full-Text
8,889,136 Full-Text
8,911,737 Full-Text
8,911,741 Full-Text
8,916,157 Full-Text
8,916,158 Full-Text
8,932,591 Full-Text
8,940,305 Full-Text
8,961,973 Full-Text
8,961,974 Full-Text
8,969,024 Full-Text
8,974,790 Full-Text
8,992,926 Full-Text
8,999,331 Full-Text
9,017,680 Full-Text
9,061,005 Full-Text
9,073,987 Full-Text
9,085,619 Full-Text
9,114,166 Full-Text
9,187,559 Full-Text
9,193,787 Full-Text
9,220,781 Full-Text
9,226,983 Full-Text

Proteins and the preparation thereof

Human antibodies that bind human TNF.alpha.
Human antibodies that bind human TNF.alpha.
Human antibodies that bind human TNFa
Antibody formulations and methods of making same
Genomic classification of malignant melanoma based on patterns
Anti-TNF-.alpha. antibodies and their uses
Human antibodies that bind human TNF.alpha.
Formulation of human antibodies for treating TNF-alpha associated
Formulation of human antibodies for treating TNF-alpha associated
Formulation of human antibodies for treating TNF-.alpha. associate
Formulation of human antibodies for treating TNF-.alpha. associate
High concentration anti-TNF.alpha. antibody liquid formulations
TNF-.alpha. binding proteins
Protein formulations and methods of making same
Methods of administering anti-TNF.alpha. antibodies
Multiple-variable dose regimen for treating TNF.alpha.-related diso
Methods of administering anti-TNF.alpha. antibodies
Formulation of human antibodies for treating TNF-alpha associated
Formulation of human antibodies for treating TNF-.alpha. associate
Formulation of human antibodies for treating TNF-.alpha. associate
Formulation of human antibodies for treating TNF-.alpha. associate
Formulation of human antibodies for treating TNF-.alpha. associate
Multiple-variable dose regimen for treating TNF.alpha.-related diso
Multiple-variable dose regimen for treating TNF.alpha.-related diso
Compositions and methods comprising binding proteins for adalim
Methods of administering anti-TNF.alpha. antibodies
Methods of administering anti-TNF.alpha. antibodies
Immunobinders directed against sclerostin
Methods of administering anti-TNF.alpha. antibodies
Multiple-variable dose regimen for treating idiopathic inflammator
Methods of administering anti-TNF.alpha. antibodies
Anti-TNF antibody formulations
Formulation of human antibodies for treating TNF-.alpha. associate
Multiple-variable dose regimen for treating idiopathic inflammator
Human antibodies that bind human TNF-alpha and methods of pre
Formulation of human antibodies for treating TNF-alpha associated
TNF-.alpha. binding proteins

ma based on patterns of gene copy number alterations

g TNF-alpha associated disorders

g TNF-alpha associated disorders
g TNF-.alpha. associated disorders
g TNF-.alpha. associated disorders
liquid formulations

TNF.alpha.-related disorders

g TNF-alpha associated disorders

g TNF-.alpha. associated disorders
g TNF-.alpha. associated disorders
g TNF-.alpha. associated disorders
g TNF-.alpha. associated disorders
TNF.alpha.-related disorders
TNF.alpha.-related disorders
ng proteins for adalimumab

diopathic inflammatory bowel disease

g TNF-.alpha. associated disorders

diopathic inflammatory bowel disease
ha and methods of preparing the same
g TNF-alpha associated disorders